COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 2216: Articles 22151-22160  | Next

Nitazoxanide and JIB-04 have broad-spectrum antiviral activity and inhibit SARS-CoV-2 replication in cell culture and coronavirus pathogenesis in a pig model
Son, J., Huang, S., Zeng, Q., Bricker, T. L., Case, J. B., Zhou, J., Zang, R., Liu, Z., Chang, X., Harastani, H. H., Chen, L., Gomez Castro, M. F., Zhao, Y., Kohio, H. P., Hou, G., Fan, B., Niu, B., Guo, R., Rothlauf, P. W., Bailey, A. L., Wang, X., Shi, P.-Y., Whelan, S. P. J., Diamond, M. S., Boon, A. C. M., Li, B., Ding, S.
10.1101/2020.09.24.312165 — Posted: 2020-09-25 Discussion: Offsite
A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters
Fagre, A., Manhard, J., Adams, R., Eckley, M., Zhan, S., Lewis, J., Rocha, S. M., Woods, C., Kuo, K., Liao, W., Li, L., Corper, A., Challa, D., Mount, E., Tumanut, C., Tjalkens, R. B., Aboelleil, T., Fan, X., Schountz, T.
10.1101/2020.09.25.313601 — Posted: 2020-09-25 Discussion: Offsite
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
Chen, J. S., Alfajaro, M. M., Wei, J., Chow, R. D., Filler, R. B., Eisenbarth, S. C., Wilen, C. B.
10.1101/2020.09.24.312769 — Posted: 2020-09-25
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes
Li, Y., Renner, D., Comar, C. E., Whelan, J., Reyes, H., Cardenas-Diaz, F. L., Truitt, R., Tan, L. H., Dong, B., Alysandratose, K. D., Huang, J., Palmer, J. N., Adappa, N. D., Kohanski, M. A., Kotton, D. N., Silverman, R. H., Yang, W., Morrisey, E., Cohen, N., Weiss, S. R.
10.1101/2020.09.24.312553 — Posted: 2020-09-25 Discussion: Onsite
Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
Proud, P. C., Tsitoura, D., Watson, R. J., Chua, B. Y., Aram, M. J., Bewley, K. R., Cavell, B. E., Cobb, R., Dowall, S., Fotheringham, S. A., Ho, C. M., Lucas, V., Ngabo, D., Rayner, E., Ryan, K. A., Slack, G. S., Thomas, S., Wand, N. I., Yeates, P., Demaison, C., Jackson, D. C., Bartlett, N. W., Mercuri, F., Carroll, M. W.
10.1101/2020.09.25.309914 — Posted: 2020-09-25
Sequence Analysis for SNP Detection and Phylogenetic Reconstruction of SARS-CoV-2 Isolated from Nigerian COVID-19 Cases
Taiwo, I. A., Adeleye, N., Anwoju, F. O., Adeyinka, A., Uzoma, I. C., Bankole, T. T.
10.1101/2020.09.25.310078 — Posted: 2020-09-25
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2
Yao, H., Cai, H., Li, T., Zhou, B., Qin, W., Lavillette, D., Li, D.
10.1101/2020.09.24.312595 — Posted: 2020-09-25
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report.
Goldman, J. D., Wang, K., Roltgen, K., Nielsen, S. C. A., Roach, J. C., Naccache, S. N., Yang, F., Wirz, O. F., Yost, K. E., Lee, J.-Y., Chun, K., Wrin, T., Petropoulos, C. J., Lee, I., Fallen, S., Manner, P. M., Wallick, J. A., Algren, H. A., Murray, K. M., Su, Y., Hadlock, J., Jeharajah, J., Berrington, W. R., Pappas, G. P., Nyatsatsang, S. T., Greninger, A. L., Satpathy, A. T., Pauk, J. S., Boyd, S. D., Heath, J. R.
10.1101/2020.09.22.20192443 — Posted: 2020-09-25 Discussion: Offsite
Outcomes associated with SARS-CoV-2 viral clades in COVID-19
Nakamichi, K., Shen, J. Z., Lee, C. S., Lee, A. Y., Roberts, E. A., Simonson, P. D., Roychoudhury, P., Andriesen, J. G., Randhawa, A. K., Mathias, P. C., Greninger, A., Jerome, K. R., Van Gelder, R. N.
10.1101/2020.09.24.20201228 — Posted: 2020-09-25
Psychological preparedness for pandemic (COVID-19) management: Perceptions of nurses and nursing students in India
Gandhi, S., Sahu, M., Govindan, R., Nattala, P., Sudhir, P. M., Balachandran, R.
10.1101/2020.09.24.20201301 — Posted: 2020-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).